CIK 0000874015
- Large accelerated filer
IONIS PHARMACEUTICALS INC
Sign in to watch- Ticker
- IONS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 330336973
- Phone
- +1 760-931-9200
- Business address
- 2855 GAZELLE COURT, CARLSBAD, CA, 92010
- Former names
- ISIS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $148,200
- in 1 filing
- Open-market sales, last 90 days
- $61,389
- in 2 filings
Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-31 | O'NEIL PATRICK R. EVP CLO & General Counsel | Other acquisition | +63 | $51.31 | $3K | 59,205 |
| 2026-06-26 | O'NEIL PATRICK R. EVP CLO & General Counsel | Sale 10b5-1 | −3,069 | $80.00 | $246K | 61,470 |
| 2026-03-09 | O'NEIL PATRICK R. EVP CLO & General Counsel | Sale 10b5-1 | −10,148 | $75.25 | $764K | 62,211 |
| 2026-02-27 | O'NEIL PATRICK R. EVP CLO & General Counsel | Other acquisition | +376 | $48.87 | $18K | 72,359 |
| 2026-01-30 | O'NEIL PATRICK R. EVP CLO & General Counsel | Sale | −6,179 | $83.53 | $516K | 71,983 |
| 2026-01-29 | O'NEIL PATRICK R. EVP CLO & General Counsel | Grant or award | +11,991 | 78,162 | ||
| 2026-01-16 | O'NEIL PATRICK R. EVP CLO & General Counsel | Sale | −9,191 | $75.84 | $697K | 66,171 |
| 2026-01-15 | O'NEIL PATRICK R. EVP CLO & General Counsel | Exercise or conversion | +21,473 | 75,362 | ||
| 2026-01-15 | O'NEIL PATRICK R. EVP CLO & General Counsel | Grant or award · Performance Restricted Stock Units | +25,800 | 90,601 | ||
| 2026-01-15 | O'NEIL PATRICK R. EVP CLO & General Counsel | Exercise or conversion · Restricted Stock Unit | −21,473 | 39,251 | ||
| 2026-01-15 | O'NEIL PATRICK R. EVP CLO & General Counsel | Grant or award · Restricted Stock Unit | +9,675 | 48,926 | ||
| 2026-01-02 | O'NEIL PATRICK R. EVP CLO & General Counsel | Grant or award · Non-Qualified Stock Option (right to buy) | +19,350 | 19,350 | ||
| 2025-10-06 | O'NEIL PATRICK R. EVP CLO & General Counsel | Exercise or conversion 10b5-1 | +10,200 | $52.87 | $539K | 67,330 |
| 2025-10-06 | O'NEIL PATRICK R. EVP CLO & General Counsel | Sale 10b5-1 | −10,200 | $69.89 | $713K | 57,130 |
| 2025-10-06 | O'NEIL PATRICK R. EVP CLO & General Counsel | Sale 10b5-1 | −3,241 | $69.27 | $224K | 53,889 |
| 2025-10-06 | O'NEIL PATRICK R. EVP CLO & General Counsel | Exercise or conversion · Non-Qualified Stock Option (right to buy) 10b5-1 | −10,200 | 17,000 | ||
| 2025-10-02 | O'NEIL PATRICK R. EVP CLO & General Counsel | Exercise or conversion 10b5-1 | +30,203 | $56.78 | $1.7M | 87,333 |
| 2025-10-02 | O'NEIL PATRICK R. EVP CLO & General Counsel | Sale 10b5-1 | −30,203 | $67.69 | $2.0M | 57,130 |
| 2025-10-02 | O'NEIL PATRICK R. EVP CLO & General Counsel | Exercise or conversion 10b5-1 | +34,461 | $60.89 | $2.1M | 91,591 |
| 2025-10-02 | O'NEIL PATRICK R. EVP CLO & General Counsel | Sale 10b5-1 | −34,461 | $67.69 | $2.3M | 57,130 |
Page 1 of 4 · 70 trades